Sirtuins and SIRT6 in Carcinogenesis and in Diet.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Oct 2019
Historique:
received: 26 09 2019
accepted: 03 10 2019
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 12 2 2020
Statut: epublish

Résumé

Sirtuins are a highly conserved family of nicotinamide adenine dinucleotide (NAD)-dependent protein lysine modifying enzymes. They are key regulators for a wide variety of cellular and physiological processes such as cell proliferation, differentiation, DNA damage and stress response, genome stability, cell survival, metabolism, energy homeostasis, organ development and aging. Aging is one of the major risk factors of cancer, as many of the physiological mechanisms and pathologies associated with the aging process also contribute to tumor initiation, growth and/or metastasis. This review focuses on one the mammalian sirtuins, SIRT6, which has emerged as an important regulator of longevity and appears to have multiple biochemical functions that interfere with tumor development and may be useful in cancer prevention and for site-specific treatment. The recent evidence of the role of SIRT6 in carcinogenesis is also discussed, focusing on the potential use of SIRT6 modulators in cancer nanomedicine.

Identifiants

pubmed: 31591350
pii: ijms20194945
doi: 10.3390/ijms20194945
pmc: PMC6801518
pii:
doi:

Substances chimiques

SIRT6 protein, human EC 3.5.1.-
Sirtuins EC 3.5.1.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Portuguese Science and Technology Foundation (FCT/MCT) and European Funds (PRODER/COMPETE)
ID : M-ERA-NET/0004/2015-PAIRED, co-financed by FEDER, under the Partnership Agreement PT2020
Organisme : FCT and Dendropharma - Investigação E Serviços De Intervenção Farmacêutica, Sociedade Unipessoal Lda
ID : PDE/00017/2013
Organisme : The Institute of Nanoscience and Nanotechnology
ID : project ART2018

Références

Trends Biochem Sci. 2014 Feb;39(2):72-81
pubmed: 24438746
Can J Cardiol. 2016 May;32(5):634-41
pubmed: 26948035
Nature. 1981 Jan 22;289(5795):239-44
pubmed: 6256655
PLoS One. 2013 Aug 28;8(8):e74340
pubmed: 24015318
J Mol Graph Model. 2014 Apr;49:38-46
pubmed: 24491483
Cell. 2014 Nov 6;159(4):956-956.e1
pubmed: 25417168
Org Biomol Chem. 2013 Aug 28;11(32):5213-6
pubmed: 23839075
Eur J Pharm Sci. 2014 Oct 15;63:71-6
pubmed: 25004411
Nature. 2003 Sep 11;425(6954):191-6
pubmed: 12939617
Mol Med Rep. 2014 Mar;9(3):882-8
pubmed: 24366394
Molecules. 2018 Jul 24;23(8):null
pubmed: 30042375
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6504-13
pubmed: 25400728
Expert Rev Clin Pharmacol. 2018 Jun;11(6):545-547
pubmed: 29667442
Neurochem Res. 2015 Jan;40(1):59-69
pubmed: 25366464
Nat Cell Biol. 2012 Nov;14(11):1203-11
pubmed: 23041974
Mol Divers. 2019 Jun 25;:null
pubmed: 31240519
Int J Biol Macromol. 2015 Jan;72:680-6
pubmed: 25224288
Handb Exp Pharmacol. 2011;206:189-224
pubmed: 21879451
Autophagy. 2018;14(3):518-533
pubmed: 29215322
Carcinogenesis. 2013 Jul;34(7):1476-86
pubmed: 23514751
Nat Med. 2009 Feb;15(2):206-10
pubmed: 19151729
Biogerontology. 2013 Dec;14(6):629-39
pubmed: 24213807
Clin Sci (Lond). 2013 Feb;124(3):153-64
pubmed: 23075334
Mol Biosyst. 2013 Jul;9(7):1789-806
pubmed: 23592245
Biochim Biophys Acta. 2015 Nov;1852(11):2442-55
pubmed: 26303641
Asian Pac J Cancer Prev. 2014;15(17):7297-301
pubmed: 25227832
Exp Cell Res. 2015 Jan 1;330(1):81-90
pubmed: 25066211
Mol Biol Cell. 2005 Oct;16(10):4623-35
pubmed: 16079181
Expert Rev Clin Pharmacol. 2019 Jan;12(1):1-7
pubmed: 30484336
Anal Biochem. 2013 May 15;436(2):78-83
pubmed: 23376017
J Endod. 2015 Oct;41(10):1631-7
pubmed: 26187426
Eur Rev Med Pharmacol Sci. 2015;19(5):818-24
pubmed: 25807436
Oncotarget. 2016 Jan 12;7(2):1144-54
pubmed: 26701732
Oncogene. 2007 Aug 13;26(37):5310-8
pubmed: 17694074
Science. 2011 Jun 17;332(6036):1443-6
pubmed: 21680843
Aging (Albany NY). 2009 Jan 20;1(1):12-6
pubmed: 20157593
Nature. 2000 Feb 17;403(6771):795-800
pubmed: 10693811
Sci Signal. 2014 Jul 29;7(336):ra71
pubmed: 25074979
Phytother Res. 2019 Sep;33(9):2221-2243
pubmed: 31359516
Patient Prefer Adherence. 2018 Oct 05;12:1975-1987
pubmed: 30323567
Chembiochem. 2016 Jan 1;17(1):77-81
pubmed: 26607666
Worm. 2014 May 08;3:e29102
pubmed: 26442197
Biochim Biophys Acta. 2015 Jul;1852(7):1311-22
pubmed: 25766107
Biochemistry. 2015 May 19;54(19):3037-3050
pubmed: 25897714
Clin Cases Miner Bone Metab. 2016 May-Aug;13(2):127-130
pubmed: 27920809
Methods Mol Biol. 2016;1436:259-69
pubmed: 27246220
Genes Cancer. 2011 Jun;2(6):648-62
pubmed: 21941620
Curr Pharm Des. 2012;18(35):5735-45
pubmed: 22726116
ACS Med Chem Lett. 2012 Oct 23;3(12):969-74
pubmed: 24900419
EMBO J. 2011 Feb 2;30(3):546-55
pubmed: 21157431
Nat Commun. 2011 Aug 16;2:433
pubmed: 21847107
Oxid Med Cell Longev. 2013;2013:707421
pubmed: 24069505
J Cell Mol Med. 2008 Jan-Feb;12(1):316-29
pubmed: 18081698
J Biol Chem. 2013 Oct 25;288(43):31350-6
pubmed: 24052263
Mol Cell. 2018 Sep 6;71(5):718-732.e9
pubmed: 30193097
Pharmacol Rep. 2015 Dec;67(6):1068-80
pubmed: 26481524
Nat Rev Drug Discov. 2009 Jul;8(7):547-66
pubmed: 19568282
PLoS One. 2014 Jun 04;9(6):e98831
pubmed: 24896097
Exp Physiol. 2011 Aug;96(8):801-15
pubmed: 21602294
Cell. 2012 Dec 7;151(6):1185-99
pubmed: 23217706
Mol Cell Biochem. 2012 May;364(1-2):345-50
pubmed: 22286818
Eur J Pharm Sci. 2017 Jan 1;96:53-61
pubmed: 27613382
Nature. 2003 May 29;423(6939):550-5
pubmed: 12754525
Gene. 2016 Jan 10;575(2 Pt 3):680-6
pubmed: 26403315
J Med Chem. 2014 Jun 12;57(11):4796-804
pubmed: 24785705
Transl Res. 2015 Mar;165(3):374-86
pubmed: 25475987
J Surg Oncol. 2015 Aug;112(2):231-7
pubmed: 26180037
Trends Biochem Sci. 2010 Aug;35(8):427-33
pubmed: 20570523
Nature. 2008 Mar 27;452(7186):492-6
pubmed: 18337721
J Stroke Cerebrovasc Dis. 2015 Mar;24(3):601-9
pubmed: 25543188
FEBS Lett. 2015 Aug 4;589(17):2274-81
pubmed: 26183563
BMC Health Serv Res. 2016 Apr 29;16:163
pubmed: 27130440
Int J Biochem Cell Biol. 2014 Apr;49:98-104
pubmed: 24495875
Bioorg Med Chem Lett. 2015 Aug 15;25(16):3319-24
pubmed: 26081291
Cell Cycle. 2009 Aug 15;8(16):2662-3
pubmed: 19597350
Acta Pharm Sin B. 2015 Mar;5(2):145-50
pubmed: 26579440
EMBO J. 2000 Mar 15;19(6):1176-9
pubmed: 10716917
Eur J Med Chem. 2015;96:245-9
pubmed: 25884115
Nature. 2013 Apr 4;496(7443):110-3
pubmed: 23552949
FEBS J. 2012 Aug;279(15):2610-23
pubmed: 22621751
Org Biomol Chem. 2014 Oct 14;12(38):7498-502
pubmed: 25163004
Sci Rep. 2018 Mar 7;8(1):4163
pubmed: 29515203
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 1;968:105-11
pubmed: 24704183
Mol Cell. 2013 Aug 22;51(4):454-68
pubmed: 23911928
Bioorg Med Chem. 2017 Oct 15;25(20):5849-5858
pubmed: 28958848
Mol Cells. 2015 Sep;38(9):750-8
pubmed: 26420294
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4774-81
pubmed: 25197348
Mol Cell. 2010 Oct 22;40(2):179-204
pubmed: 20965415
J Endod. 2014 Mar;40(3):393-8
pubmed: 24565659
Clin Epigenetics. 2010 Dec;1(3-4):71-83
pubmed: 22704201
BMC Womens Health. 2017 Sep 5;17(1):73
pubmed: 28870183
Curr Biol. 2015 Jun 29;25(13):R569-83
pubmed: 26126285
Cancer Res. 2014 Oct 15;74(20):5925-33
pubmed: 25320180
BMB Rep. 2013 Sep;46(9):429-38
pubmed: 24064057
Cell Cycle. 2011 Sep 15;10(18):3153-8
pubmed: 21900744
Osteoarthritis Cartilage. 2015 Aug;23(8):1412-20
pubmed: 25819580
Mol Cell. 2012 Dec 28;48(6):900-13
pubmed: 23142079
Semin Cell Dev Biol. 2015 Jul;43:33-42
pubmed: 26238985
Carcinogenesis. 2016 Feb;37(2):108-18
pubmed: 26717993
Eur J Med Chem. 2015 Sep 18;102:530-9
pubmed: 26310895
Br J Clin Pharmacol. 2018 Apr;84(4):659-672
pubmed: 29433155
Cell. 2010 Jan 22;140(2):280-93
pubmed: 20141841
Cell. 2006 Jan 27;124(2):315-29
pubmed: 16439206
J Intern Med. 2008 Feb;263(2):128-41
pubmed: 18226091
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Curr Opin Clin Nutr Metab Care. 2015 Nov;18(6):521-7
pubmed: 26335311
Aging (Albany NY). 2009 Feb 13;1(2):182-90
pubmed: 20157508

Auteurs

Maria de Céu Teixeira (M)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra (FFUC), Polo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal. mceuteixeira1@gmail.com.

Elena Sanchez-Lopez (E)

Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain. esanchezlopez@ub.edu.
Institute of Nanoscience and nanotechnology (IN2UB), Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain. esanchezlopez@ub.edu.
CIBERNED Centros de Biomedicina en Red de Enfermedades Neurodegenerativas, Facultat de Farmàcia, Universitat de Barcelona, 08028 Barcelona, Spain. esanchezlopez@ub.edu.

Marta Espina (M)

Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain. m.espina@ub.edu.
Institute of Nanoscience and nanotechnology (IN2UB), Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain. m.espina@ub.edu.

Maria Luisa Garcia (ML)

Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain. marisagarcia@ub.edu.
Institute of Nanoscience and nanotechnology (IN2UB), Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain. marisagarcia@ub.edu.
CIBERNED Centros de Biomedicina en Red de Enfermedades Neurodegenerativas, Facultat de Farmàcia, Universitat de Barcelona, 08028 Barcelona, Spain. marisagarcia@ub.edu.

Alessandra Durazzo (A)

CREA-Research Centre for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy. alessandra.durazzo@crea.gov.it.

Massimo Lucarini (M)

CREA-Research Centre for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy. massimo.lucarini@crea.gov.it.

Ettore Novellino (E)

Department of Pharmacy, University of Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy. ettore.novellino@unina.it.

Selma B Souto (SB)

Department of Endocrinology of Hospital de São João, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal. sbsouto.md@gmail.com.

Antonello Santini (A)

Department of Pharmacy, University of Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy. asantini@unina.it.

Eliana B Souto (EB)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra (FFUC), Polo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal. ebsouto@ff.uc.pt.
CEB-Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. ebsouto@ff.uc.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH